Actively Recruiting

Age: 10Years - 60Years
All Genders
NCT05619068

The Evolution and Prognosis of Moyamoya Disease

Led by Chinese PLA General Hospital · Updated on 2022-12-21

300

Participants Needed

1

Research Sites

278 weeks

Total Duration

On this page

Sponsors

C

Chinese PLA General Hospital

Lead Sponsor

B

Beijing Tiantan Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

To investigate the evolution of imaging appearances and cognitive function of Moyamoya disease (MMD) and to establish a prognosis evaluation system based on imaging biomarkers in MMD. The study may be helpful to optimize and improve the diagnosis and pretreatment assessment of MMD, and provide an important theoretical supplement to the existing guidelines for the management of MMD.

CONDITIONS

Official Title

The Evolution and Prognosis of Moyamoya Disease

Who Can Participate

Age: 10Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with Moyamoya disease confirmed by conventional angiography or MRI following official guidelines
  • Age older than 10 years and younger than 60 years
  • Education level of primary school or above (at least 6 years of education)
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Patients with massive cerebral infarction, multiple paraventricular ischemic foci, or significantly enlarged ventricular hydrocephalus after intracerebral hemorrhage
  • Patients with vascular diseases caused by immune system disorders
  • Inability to cooperate with cognitive function testing
  • Presence of other neuropsychiatric diseases affecting cognition such as Alzheimer's disease, Parkinson's disease, depression, anxiety disorder, cerebral hemorrhage, hydrocephalus, or brain trauma
  • Contraindications to MRI scanning including having pacemakers, nerve stimulators, artificial metal heart valves, or other metal foreign bodies
  • Inability to complete imaging procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chinese PLA General Hospital

Beijing, Beijing Municipality, China, 100853

Actively Recruiting

Loading map...

Research Team

J

Jinhao Lyu

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Evolution and Prognosis of Moyamoya Disease | DecenTrialz